SUMMARY
Pharmacotherapy efficiency for ophthalmology patients with primary open angle glaucoma depends both on pathological process features and physician’s qualification, and on the ability of funds rising to purchase antiglaucoma drugs, as well. One of the pharmaceutical provision optimization mechanisms for the given group of patients is the implementation of the formulary system and mandatory health insurance.Conclusion. The data, obtained in result of the ABC/VEN/frequency analysis of AGD use, show the necessity of pharmacotherapy optimization for patients having POAG, based on the results of complex pharmacoeconomic studies, under conditions of reforming health care system concerning the insurance medicine implementation in Ukraine